Vaxxinity, Inc. — Form D
Vaxxinity, Inc. of DALLAS, TX, a company, filed a Form D exempt-offering notice with the SEC on 2021-03-31. The offering totals $100.0M, of which $27.0M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2021-03-31
- Form: D
- Accession: 0001851657-21-000003
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $100.0M
- Amount sold: $27.0M
- Remaining: $73.0M
- Investors: 9
- Date of first sale: 2021-03-17
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-394199
Issuer
- Name: Vaxxinity, Inc.
- CIK: 0001851657
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2021
- Address: 1717 MAIN STREET, DALLAS, TX, 75201
- Phone: (917)855-3860
Officers, directors & promoters (6)
| Name | Role | Location |
|---|
| James Chui | Director | VANCOUVER, A1 |
| Peter Diamandis | Director | Santa Monica, CA |
| Mei Mei Hu | Director | Dallas, TX |
| Louis Reese | Director | Dallas, TX |
| Dakin Sloss | Director | BERKELEY, CA |
| Mei Mei Hu | Executive Officer | Dallas, TX |
Other filings by this issuer (1)
More